Polymyxin use associated with respiratory arrest

Chest

Volumn 141, Issue 2, 2012, Pages 515-517

  Wunsch, Hannah ^a   Moitra, Vivek K ^a   Patel, Mona ^b   Dzierba, Amy L ^b  

^a Och Spine at New York Presbyterian Hospitals   (United States)

^b NEW YORK PRESBYTERIAN HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMIKACIN; CREATININE; FLUCONAZOLE; LEVOFLOXACIN; MEROPENEM; METRONIDAZOLE; POLYMYXIN B; TIGECYCLINE;

ADULT; ARTICLE; CASE REPORT; CREATININE BLOOD LEVEL; ENDOTRACHEAL INTUBATION; GRAFT RECIPIENT; HOSPITAL INFECTION; HUMAN; KIDNEY TRANSPLANTATION; KLEBSIELLA PNEUMONIAE INFECTION; LIVER TRANSPLANTATION; LOADING DRUG DOSE; MALE; PERIRENAL ABSCESS; PRIORITY JOURNAL; RESPIRATORY ARREST; RESUSCITATION; SEPSIS;

EID: 84856713408     PISSN: 00123692     EISSN: 19313543     Source Type: Journal    
DOI: 10.1378/chest.11-1483     Document Type: Article

References (13)

1. Chen LF, Kaye D. Current use for old antibacterial agents: polymyxins, rifamycins, and aminoglycosides. Infect Dis Clin North Am. 2009;23(4):1053-1075.
2. Peleg AY, Hooper DC. Hospital-acquired infections due to gram-negative bacteria. N Engl J Med. 2010;362(19):1804-1813.
3. Sokoll MD, Gergis SD. Antibiotics and neuromuscular function. Anesthesiology. 1981;55(2):148-159. (Pubitemid 11034210)
4. Sabawala PB, Dillon JB. The action of some antibiotics on the human intercostal nerve-muscle complex. Anesthesiology.1959;20:659-668.
5. Pohlmann G. Respiratory arrest associated with intravenous administration of polymyxin B sulfate. JAMA. 1966;196(2):181-183.
6. Lindesmith LA, Baines RD Jr, Bigelow DB, Petty TL. Reversible respiratory paralysis associated with polymyxin therapy. Ann Intern Med. 1968;68(2):318-327.
7. Falagas ME, Kasiakou SK. Toxicity of polymyxins: a systematic review of the evidence from old and recent studies. Crit Care.2006;10(1):R27.
8. Timmerman JC, Long JP, Pittinger CB. Neuromuscular blocking properties of various antibiotic agents. Toxicology.1959;1(3):299-304.
9. Lee C, Chen D, Nagel EL. Neuromuscular block by antibiotics: polymyxin B. Anesth Analg. 1977;56(3):373-377. (Pubitemid 8118824)
10. Zavascki AP, Goldani LZ, Cao G, et al. Pharmacokinetics of intravenous polymyxin B in critically ill patients. Clin Infect Dis.2008;47(10):1298-1304.
11. Mendes CA, Cordeiro JA, Burdmann EA. Prevalence and risk factors for acute kidney injury associated with parenteral polymyxin B use. Ann Pharmacother. 2009;43(12):1948-1955.
12. Naranjo CA, Busto U, Sellers EM, et al. A method for estimating the probability of adverse drug reactions. Clin Pharmacol Ther. 1981;30(2):239-245. (Pubitemid 12149145)
13. Giske CG, Monnet DL, Cars O, Carmeli Y; on behalf of the ReAct-Action on Antibiotic Resistance. Clinical and economic impact of common multidrug-resistant gram-negative bacilli. Antimicrob Agents Chemother. 2008;52(3):813-821. (Pubitemid 351358357)